BioCentury | Aug 2, 2019
Translation in Brief

A charged system for insulin delivery

...programs supported by the non-profit JDRF. Others include technology from SmartCells Inc., Glycostasis Inc. and Ziylo Ltd....
BioCentury | Oct 6, 2018
Finance

In sight of uncharted territory

...10x Genomics Inc. Epinomics Inc. 8/28/18 ND ND ND Novo Nordisk A/S (CSE:NOVO B; NYSE:NVO) Ziylo Ltd....
BioCentury | Sep 21, 2018
Company News

Novo's R&D restructuring adds to innovation push

...recent deals have reflected the pharma's innovation initiative. In August, Novo acquired smart insulin company Ziylo Ltd....
BioCentury | Sep 18, 2018
Company News

Novo's R&D restructuring adds to innovation push

...recent deals have reflected the pharma's innovation initiative. In August, Novo acquired smart insulin company Ziylo Ltd....
BioCentury | Sep 1, 2018
Politics, Policy & Law

Back to School 2018: A pathway to Biopharma 3.0

...a mechanism for stopping signaling when glucose levels fall. Novo Nordisk A/S’s August acquisition of Ziylo Ltd....
...Calif. UCB S.A. (Euronext:UCB), Brussels, Belgium U.S. Food and Drug Administration (FDA), Silver Spring, Md. Ziylo Ltd....
BioCentury | Aug 31, 2018
Company News

Novo acquires Ziylo in quest for glucose-sensitive insulin

...Novo Nordisk A/S (CSE:NOVO B; NYSE:NVO) acquired Ziylo Ltd. (Bristol, U.K.), giving the pharma a platform that...
...monitoring. Novo declined to disclose financial terms. Novo Nordisk A/S (CSE:NOVO B; NYSE:NVO), Bagsvaerd, Denmark Ziylo Ltd....
BioCentury | Aug 23, 2018
Product R&D

Sweet switch

...Novo Nordisk A/S is betting Ziylo Ltd.’s glucose-responsive compounds can unlock development of smart insulins that are...
BioCentury | Aug 17, 2018
Company News

Novo acquires Ziylo in quest for glucose-sensitive insulin

...Novo Nordisk A/S (CSE:NOVO B; NYSE:NVO) acquired Ziylo Ltd. (Bristol, U.K.), giving the pharma a platform that...
...for non-therapeutic applications, including continuous glucose monitoring. Novo declined to disclose financial terms. Jennie Walters Novo Nordisk A/S Ziylo Ltd....
Items per page:
1 - 8 of 8
BioCentury | Aug 2, 2019
Translation in Brief

A charged system for insulin delivery

...programs supported by the non-profit JDRF. Others include technology from SmartCells Inc., Glycostasis Inc. and Ziylo Ltd....
BioCentury | Oct 6, 2018
Finance

In sight of uncharted territory

...10x Genomics Inc. Epinomics Inc. 8/28/18 ND ND ND Novo Nordisk A/S (CSE:NOVO B; NYSE:NVO) Ziylo Ltd....
BioCentury | Sep 21, 2018
Company News

Novo's R&D restructuring adds to innovation push

...recent deals have reflected the pharma's innovation initiative. In August, Novo acquired smart insulin company Ziylo Ltd....
BioCentury | Sep 18, 2018
Company News

Novo's R&D restructuring adds to innovation push

...recent deals have reflected the pharma's innovation initiative. In August, Novo acquired smart insulin company Ziylo Ltd....
BioCentury | Sep 1, 2018
Politics, Policy & Law

Back to School 2018: A pathway to Biopharma 3.0

...a mechanism for stopping signaling when glucose levels fall. Novo Nordisk A/S’s August acquisition of Ziylo Ltd....
...Calif. UCB S.A. (Euronext:UCB), Brussels, Belgium U.S. Food and Drug Administration (FDA), Silver Spring, Md. Ziylo Ltd....
BioCentury | Aug 31, 2018
Company News

Novo acquires Ziylo in quest for glucose-sensitive insulin

...Novo Nordisk A/S (CSE:NOVO B; NYSE:NVO) acquired Ziylo Ltd. (Bristol, U.K.), giving the pharma a platform that...
...monitoring. Novo declined to disclose financial terms. Novo Nordisk A/S (CSE:NOVO B; NYSE:NVO), Bagsvaerd, Denmark Ziylo Ltd....
BioCentury | Aug 23, 2018
Product R&D

Sweet switch

...Novo Nordisk A/S is betting Ziylo Ltd.’s glucose-responsive compounds can unlock development of smart insulins that are...
BioCentury | Aug 17, 2018
Company News

Novo acquires Ziylo in quest for glucose-sensitive insulin

...Novo Nordisk A/S (CSE:NOVO B; NYSE:NVO) acquired Ziylo Ltd. (Bristol, U.K.), giving the pharma a platform that...
...for non-therapeutic applications, including continuous glucose monitoring. Novo declined to disclose financial terms. Jennie Walters Novo Nordisk A/S Ziylo Ltd....
Items per page:
1 - 8 of 8